chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax FEB96&began vomiting&was diff to awaken;presented to ER where MD noted poor tracking of pupils (equally round,reactive to light)&tachycardia 130;BP was 120/100;MD feels pt is hypotonic,hyporesponsive&encephalographic;
Woke up 2 days later with hives on neck and swollen face with low grade fever. Eyes swollen shut and ear lobe swollen. Reported to office on the following day,  no fever but every time lays down her face gets more swollen on that side. Patient has history of peanut allergy and she works at an ice cream shop. Mom giving Benadryl, no breathing issues, can swallow fine. Redness on face better but back red and full of hives.
Erythema & edema of arm injected & fever 102 occurred w/in 12 hrs of inject;
Patient began feeling chest pain/tightness and back pain minutes after receiving shot.  EMS was contacted and provided care upon arrival.  Four doses of 81 mg aspirin were given.  Patient recovered after roughly 30 minutes and went home on her own.
Achy; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achy) and CHILLS (chills) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (Achy) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, MYALGIA (Achy) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient was doing fine after receiving both shots of the vaccine. Concomitant medications were not provided.    This case was linked to MOD-2021-058087 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event details updated
Strep pneumoniae, pneumonia and empyema. Decortication and chest tube; serotype 19.
Headache, fever, malaise, chills, sweating, joint aches that all last for a day.  Patient also had redness, swelling and pain in left arm that radiated to neck (not at injection site but on side of arm).
Urinary tract infection; This is a spontaneous report received from a contactable consumer from medical information team. The reporter is the patient.  A 94-year-old female patient received BNT162B2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. Relevant medical history included: "Systemic mastocytosis" (unspecified if ongoing); "Coronary artery disease" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: URINARY TRACT INFECTION (non-serious) with onset Mar2021, outcome "unknown", described as "Urinary tract infection".  Additional Information: The patient received the first dose of the COVID-19 vaccine 05Mar2021 and was scheduled for her second dose on this upcoming Friday, 4 weeks later. The patient would like to know whether that is okay. Following the first dose of the vaccine, the patient had a urinary tract infection (UTI). The patient has had it for about 10 days. The patient was set to start her prescription of antibiotics today or tomorrow; would like to know whether she can start her antibiotics today or tomorrow.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Injection given at 4 p.m. by 4:03 p.m. my tongue started to tingle and then turned into a burning sensation by 4:10 my tongue had began to adversely swell to twice its size. I inform the nurses and was immediately taken to the ER where they noticed that my tongue was extremely swollen my throat was beginning to swell and that I had raised up bumps and lesions starting to form on the back side of my tongue. ER staff admitted me and began me on a IV steroid treatment accompanied with Pepcid and Benadryl After 2 hours in the ER under close observation my tongue was still swollen and my windpipe was in danger of being closed off so I was transported via ambulance to Hospital and admitted to Intensive Care Unit where they continued to administer steroids and Benadryl. By 2 a.m. my condition had not improved and I was given an EpiPen in my arm. The EpiPen did help but by 6 a.m. my tongue swelling had returned but not as severe. On march 24th The hospital then moved me from the ICU  to the cardiac wing to be placed on a heart monitor as they continue to administer steroids, Benadryl, and Pepcid. I was given another Epi Pen by 11 a.m.  in the cardiac  care unit due to my tongue beginning to severely swell again.  As of today, March 25th My tongue continues to swell and they still have me admitted to the hospital as they continue to observe me and continue to administer steroids and Benadryl all via my i.v. port. Today they are going to begin me on an oral Prednisone.
Pain began in the evening and progressively got worse. Pain and swelling to the elbow by the morning. Redness and pain to the whole arm.  Went to the ER on Monday the 19th and was started on Keflex and pain medication. Calmed it down. Was on Vicodin for pain. Redness and swelling are gone but it still hurts when he moves his arm.
Four days after the shot, patient started having blood clots in the urine.    After a few weeks, was able to get back to normal but seemed to stimulate previously stable cancers into growth. Four days after the 2nd (3/19/21) covid shot blood clots started again.
Donor fainted after immunization. Out for 5 seconds. Given ice pack, 4 oz water and support care.
Severe tenderness is arm within 15 minutes of receiving vaccine. Uncontrollable muscle spams all over the body, shaking and severe joint pain. Weakness in arms and legs.
Within the first week after the vaccine, I began to get zapping electrical-like pains in the nerves in my fingertips and heels of my feet.  I developed sharp twitching of my limbs, fingers, and one night, even my tongue. A mild tremor that I had been feeling since a prior medication reaction (Tamoxifen) suddenly escalated.  Over the next week, the tremor began to have the same electrical quality in my upper arms and legs. It reminds me at times of that feeling when you chew on tinfoil. The shaking (whole body) wakes me at night and at times makes it impossible to drive, write, weave, or play my musical instrument. This week, I've had moments where my head literally wags like a dog's tail. My feet Charlie horse painfully. My upper arms and legs are developing a pervasive weakness, and I'm now unsteady on my feet. I'm sleeping more, napping many times in a day, and my usually boundless physical stamina is gone. Today I've had times of breathlessness. I can no longer function normally. If this continues, I will end up "disabled".
Chills; Fever 103.9; Pulseox92; Cough; DOSE 3 on 01Nov2021 and Flu vaccine on 01Nov2021; DOSE 3 on 01Nov2021 and Flu vaccine on 01Nov2021; dose received 3; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 79 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Nov2021 12:00 (Lot number: 32030BD) at the age of 79 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administered in arm left, administration date 01Nov2021 (Batch/Lot number: unknown) as dose 1 for immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing); "Secondary hypogonadis" (unspecified if ongoing), notes: Secondary hypogonadis; "Hyperthyroid" (unspecified if ongoing), notes: Hyperthyroid. Concomitant medication(s) included: ANDROGEL; TAPAZOLE; MAXZIDE. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE,Lot number: E29261, Anatomical location: Left arm, Administration time: 11:00.), administration date: 22Jan2021, when the patient was 79 years old, for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE,Lot number: BN6201, Anatomical location: Left arm, Administration time: 10:45.), administration date: 12Feb2021, when the patient was 79 years old, for COVID-19 immunisation. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 01Nov2021 12:00, outcome "unknown" and all described as "DOSE 3 on 01Nov2021 and Flu vaccine on 01Nov2021"; IMMUNISATION (non-serious) with onset 01Nov2021 12:00, outcome "unknown", described as "dose received 3"; CHILLS (non-serious) with onset 03Nov2021 01:00, outcome "recovered" (Nov2021), described as "Chills"; PYREXIA (non-serious) with onset 03Nov2021 01:00, outcome "recovered" (Nov2021), described as "Fever 103.9"; OXYGEN SATURATION DECREASED (non-serious) with onset 03Nov2021 01:00, outcome "recovered" (Nov2021), described as "Pulseox92"; COUGH (non-serious) with onset 03Nov2021 01:00, outcome "recovered" (Nov2021), described as "Cough". Relevant laboratory tests and procedures included Body temperature was 103.9, Pulse oximetry was 92, PCR Nasal swab was Negative are available in the appropriate section. Therapeutic measures were not taken as a result of chills, pyrexia, oxygen saturation decreased, cough.  Follow-up attempts completed. No further information expected.
Patient was administered with Bexsero / the vaccine had expired / March 2021; patient felt lightheaded for two minutes soon after the administration; This case was reported by a nurse via sales rep and described the occurrence of light headedness in a 18-year-old male patient who received Men B NVS (Bexsero) (batch number ABXA15AA, expiry date 31st March 2021) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   The patient's past medical history included anxiety (had preexisting anxiety problems and used to experience lightheadedness during dentist visits and prior vaccinations).   On 30th April 2021, the patient received Bexsero. On an unknown date, the patient started Bexsero Pre-Filled Syringe Device. On an unknown date, less than a week after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced light headedness and expired vaccine used. On an unknown date, the outcome of the light headedness and expired vaccine used were unknown.   It was unknown if the reporter considered the light headedness to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received Bexsero and the nurse then noticed that the vaccine had expired.  The patient received Bexsero dose that had expired in March 2021, which led to expired vaccine used. The patient felt lightheaded for two minutes soon after the administration of the dose. The reporter consented to follow up. This case US2021096005 is a duplicate of US2021095993. All future correspondence will be submitted to US2021095993.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021096005:FU 1 (deleted)
8 hrs post Anthrax vaccination #6, pruritic discrete macular erythemic rash began on B volar forearms without resolution over 48 hours, treatment with typical triamcinalone and po Benadryl.
Cellulitis of the left deltoid - area tender, hot to touch with defined border, no streaking. Pt was placed on 10 days Cephalexin.
pharmacist did not dilute vaccine before giving vaccination. patient received 0.3ml of undiluted vaccine resulting in higher dose than authorized.  pharmacist informed parent (father) and pediatrician.  pharmacist filled out incident report for pharmacy and VAERS report.  pharmacist also called pfizer support line.  patient has not experienced any side effects at time of reporting.
A few hours after the vaccine the pt became short of breath and wheezy, shortly after became itchy. She used her albuterol inhaler, took Benadryl and went to sleep. Today her itching returned today and she devolved a  rash and hives. She came to the ER, was treated with Benadryl, Pepcid, methylprednisolone, and IM epinephrine, and IV fluids. Her symptoms resolved in the ER and she was observed x2 hours, and discharged with a prescription for oral steroids.
Kinrix as the first dose in an unvaccinated patient; Kinrix as the first dose in an unvaccinated patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   Additional patient notes included did not had any prior history of vaccines.   On an unknown date, the patient received the 1st dose of Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix as the first dose in an unvaccinated patient) and inappropriate dose of vaccine administered (Verbatim: Kinrix as the first dose in an unvaccinated patient). The outcome of the inappropriate age at vaccine administration and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-Nov-2023 A pharmacist contacted GlaxoSmithKline via phone and inquiring about Kinrix and what information was available about the administration of Kinrix in a patient that comes from another country and did not had any prior history of vaccines.  The call dropped and a callback was made but the reporter did not answer the phone. The Vaccine Administration Facility was the same as Primary Reporter. An unvaccinated patient received a dose of Kinrix at an inappropriate age, which led to inappropriate age at vaccine administration and inappropriate dose of vaccine administered.
Information regarding PREVNAR was received from a consumer regarding a 3-year-old male patient who experienced pneumococcal pneumonia. The patient received a dose of an unspecified date. Relevant medical history was not provided. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day. Concomitant medications were not reported. On an unspecified date in Apr-2007, the patient was hospitalized with pneumococcal pneumonia. The patient's mother questioned the length of PREVNAR immunity (drug ineffective). She did not known if the patient had 3 or 4 injections of PREVNAR or if a specific serotype of pneumococcal infection had been determined. Caller declined to provide any further details stating that the child has a doctor's appointment on 19-Apr-2007. The patient's outcome is unknown. No additional information was available at the time of this report.
Information has been received from a pharmacist concerning a nurse who on an unspecified date developed a zoster-like rash. The nurse administered doses of Zostavax at a clinic. No further information was provided. Follow up information received from the pharmacist confirmed that a health care worker who administers the vaccine came down with a confirmed case of zoster. The worker was not previously vaccinated. Additional information is not expected. This is one of several reports from the same source.
pt recv vax;devel an inject site rxn characterized by soreness,redness & irritation;
On 4/17/19 rash broke out on left forehead. Painful rash, blistery, new rash around eyelids. Shingles on left eyelid. Erythromycin ophthalmic ointment prescribed. Valacyclovir prescribed. VALTREX 1gm one tid x 7 days. Rash also on scalp as of 4/24/19 started Bacitracin ointment 2% twice daily.
Information has been received from a nurse practitioner concerning a 34 year old female, with type 2 diabetes, who on 06-DEC-2007 was vaccinated with her first dose of GARDASIL (lot # 659653/1448U).  The patient developed shortness of breath for about 24 hours after her first dose of GARDASIL.  The patient sought medical attention.  No labs or diagnostic studies were performed.  The patient recovered from shortness of breath.  Additional information has been requested.
The muscle of my upper arm was sore the day of my shot through Saturday. Approximately 1:30pm the day following my second dose I felt very warm to the touch,  had chills and a headache. I took 500mg of acetaminophen to alleviate these symptoms. The chills eased up slightly, but the headache was ongoing through the remainder of the day and into the early morning of Friday, April 23.  I took acetaminophen throughout the day and night per instructions on the package.  Additionally, I noticed multiple red, raised and itchy splotches around the injection site on Saturday, April 24. I took Benadryl to combat the itching. As of Monday, April 26 the redness, swelling and splotches have just about completely disappeared. Around the injection site it still feels a little tender and warm, but not unbearable.
The patient experienced a non allergic rash around the injection site. She reported this event to myself (immunizing pharmacist) on 3/4/15.  She did not seek medical attention.  The rash was discribed as burning, red, and not itchy.
left eye pain and redness, red patches and swelling under left eye started out slight and has swollen bag under eye, itchy eyes, redness and tingling in the area has also moved to my upper eyelid and eyebrow/temple area.  Left cheek and left side of head are tingling.
I experienced extreme muscle soreness, fatigue, and headache for one week following the injection to the point that I was unable to move out of bed.  After one week, I woke up with a stiff neck on my left side and was unable to move my head.  One week later when I was able to exercise again, during a routine exercise that I had done with no problem for years, my left shoulder gave out and I experienced a shooting nerve pain from my left shoulder blade up through my head.   I am in remission for the past year from chronic secondary amenorhea (5 years without menstruation) and did not get my period right after the shot.  Since then, my periods have been extremely heavy for 1.5 days and cramps have been debilitating.  My period also comes earlier and duration is shorter but heavier.  If I experience any sort of stress or excitement, I experience immediate and painful cramps, spotting, debilitating pain in my right shoulder blade and head for several days.  I also experience aching pain in my hips during the night that causes me to wake up in pain.
moves his left arm it is annoying; Little bit of ache in his left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (moves his left arm it is annoying) and ARTHRALGIA (Little bit of ache in his left shoulder) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016321A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (moves his left arm it is annoying) and ARTHRALGIA (Little bit of ache in his left shoulder). At the time of the report, PAIN IN EXTREMITY (moves his left arm it is annoying) and ARTHRALGIA (Little bit of ache in his left shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided
Arm numbness after getting flu shot, tingling, redness near the vaccine injection site, redness area smaller than pinkie nail.
Case completed Covid vaccine series on 2/6/2021, and was admitted to hospital 8/6/2021 for Covid pneumonia.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 67-year-old female patient received PREVNAR 13, via an unspecified route of administration, 2 weeks before the report, at single dose. Relevant medical history and concomitant medications were not reported. The patient experienced unexplained sweats and chest pressure a week after vaccination and presented to emergency room. The doctors could not find any explanation. 2 weeks later she was admitted to hospital due to the events. Full work-up was done: no reason for her symptoms was found. Patient was otherwise in good health. Outcome of the events was unknown.
Information has been received from other company Pfizer (2015025790) on 29-JAN-2015. This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information concerning the patient's relevant medical history was reported. On an unknown date, the patient experienced an allergic reaction to PNEUMOVAX 23. The outcome of the event was unknown. The allergy reaction was considered to be related to PNEUMOVAX 23. Additional information has been requested.
Patient became altered and unresponsive to simple commands within 2 days of 2nd Moderna Covid-19 Vaccine
No adverse event but patient received a Hepatitis A instead of a Hepatitis B at 1 month old.
I have had heart palpitations ,chest pain , shortness of breath, fatigue, and more recently coronary vasospasm . This start with in three days of  my second vaccine and continues to persist. I  fear that the vasospasms will cut off blood flow to my heart and cause a heart attack.
Information has been received from a physician concerning a female (age unknown), who was vaccinated on 25-MAY-2007 with a 0.5 mL dose of Gardasil. Shortly post-vaccination the patient developed a rash on her arms and legs. The physician reported that the client did not report the rash away, but presented, with the rash to the office. A steroid dose pack was the treatment prescribed. At the time of the report, the patient had not recovered. No product quality complaint was involved.
I had a cough and a little bit of wheezing. Then, it got to where I couldn't breathe. I tested myself at home and tested negative. I contacted my doctor and told her I tested negative, and I asked if they would prescribe Antibiotics and they did. A few days went by, and I was not getting better. I was sweating in the middle of the night and decided to test again and tested positive. The next day I started having chest pains and I thought I was having a heart attack, so I went to the hospital. They ran some tests and told me that everything inside of me was inflamed. They treated me there and prescribed some medication, but I am unable to recall the medications. I was sick for about 3 months and then fatigued for another 3 months after that. I was unable to eat and lost 15 pounds.